# AbCellera Biologics Inc.: Form 8-K, filed Feb 24, 2026

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2026-02-24
- Accepted by EDGAR: Feb 24, 2026, 16:15 ET
- Period: 2026-02-24
- Accession: 0001703057-26-000010
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000170305726000010/abcl-20260224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000170305726000010/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000170305726000010/abcl-20260224.htm

Filed Feb 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001703057-26-000010. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
